arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Monte Rosa Therapeutics, Inc.

GLUE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$23.79
Today
as of Jul 22, 16:49 ET
Last 30 days +31.29% Jun 15 → Jul 22
$17.22 $19.19 $21.16 $23.13 $25.10 Jun 15 Jun 23 Jun 30 Jul 08 Jul 15 Jul 22
Open
$17.45
High
$17.80
Low
$16.25
Volume
$949,038
Avg Vol
$1M
Mkt Cap
$2.0B
P/E (TTM)
—
Beta
—
52w High
$25.77
52w Low
$4.12
Div Yield
—
Shares Out
$84M

Recent Press Releases & News last 60 days · 3 items

Jul 2 · 20:01 PR GlobeNewswire
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 3 · 18:00 Insider Monkey
Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy
Jun 2 · 20:01 PR GlobeNewswire
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Overview

52-week range
$4.12
$26
91% of range
Avg surprise (last 3)
+109.5%
Avg reaction (last 2)
+3.4%
50% positive
Latest IV / EM
138%
EM ±31.5% · $25 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.45$-0.20$0.06$0.32$0.57 Actual $0.57Est $-0.24Actual $-0.15Est $-0.31Actual $-0.45Est $-0.28 Mar/2025Jun/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-45M$-11M$22M$56M$89M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.45 $-0.28 -60.7% -178.9% -2.8% earnings
Thu Aug 7, 2025Jun/2025 $-0.15 $-0.31 +51.6% — — earnings
Thu May 8, 2025Mar/2025 $0.57 $-0.24 +337.5% — +9.6% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 6, 2026Jun/2026OTHER -$0.25-$0.15 -66.7%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$4M—$13M$23M$85M—$9M$5M
Cost of revenue————————
Gross profit————————
Operating income$-50M—$-33M$-16M$44M—$-27M$-33M
Net income$-45M—$-27M$-12M$47M—$-24M$-30M
EPS (diluted)————————

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$160M$130M$208M$69M$79M$224M$126M$109M
Inventory————————
Total current assets$678M$393M$402M$299M$332M$377M$251M$278M
Total assets$736M$449M$460M$360M$393M$439M$315M$344M
Long-term debt————————
Total liabilities$215M$216M$214M$92M$118M$216M$110M$119M
Total equity$522M$233M$246M$268M$275M$223M$205M$225M

Implied volatility — last 90 days

85%226%367%509%650% Jun 08 — IV 263% · EM ±34.7%Jun 10 — IV 284% · EM ±33.6%Jun 11 — IV 273% · EM ±30.1%Jun 12 — IV 137% · EM ±14.0%Jun 15 — IV 343% · EM ±24.8%Jun 16 — IV 467% · EM ±27.6%Jun 17 — IV 650% · EM ±27.2%Jun 19 — IV 137% · EM ±30.2%Jun 22 — IV 146% · EM ±30.4%Jun 23 — IV 111% · EM ±22.7%Jun 24 — IV 145% · EM ±29.0%Jun 25 — IV 99% · EM ±19.3%Jun 26 — IV 85% · EM ±16.3%Jun 29 — IV 117% · EM ±20.8%Jun 30 — IV 101% · EM ±17.4%Jul 01 — IV 130% · EM ±21.6%Jul 02 — IV 144% · EM ±23.3%Jul 03 — IV 149% · EM ±23.3%Jul 07 — IV 142% · EM ±18.8%Jul 08 — IV 165% · EM ±20.6%Jul 09 — IV 120% · EM ±14.2%Jul 13 — IV 181% · EM ±15.1%Jul 14 — IV 309% · EM ±22.4%Jul 15 — IV 365% · EM ±21.6%Jul 16 — IV 538% · EM ±22.5%Jul 20 — IV 135% · EM ±31.8%Jul 21 — IV 132% · EM ±30.7%Jul 22 — IV 138% · EM ±31.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in